Change of Therapeutic Response Classification According to Recombinant Human Thyrotropin-Stimulated Thyroglobulin Measured at Different Time Points in Papillary Thyroid Carcinoma | Zendy

Jang Bae Moon | Zendy; Subin Jeon | Zendy; Ki Seong Park | Zendy; Su Woong Yoo | Zendy; SaeRyung Kang | Zendy; SangGeon Cho | Zendy; Jahae Kim | Zendy; Changho Lee | Zendy; HoChun Song | Zendy; JungJoon Min | Zendy; HeeSeung Bom | Zendy; Seong Young Kwon | Zendy

Open Access

Change of Therapeutic Response Classification According to Recombinant Human Thyrotropin-Stimulated Thyroglobulin Measured at Different Time Points in Papillary Thyroid Carcinoma

Author(s) -

Jang Bae Moon,

Subin Jeon,

Ki Seong Park,

Su Woong Yoo,

SaeRyung Kang,

SangGeon Cho,

Jahae Kim,

Changho Lee,

HoChun Song,

JungJoon Min,

HeeSeung Bom,

Seong Young Kwon

Publication year - 2021

Publication title -

nuclear medicine and molecular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.534

H-Index - 23

eISSN - 1869-3482

pISSN - 1869-3474

DOI - 10.1007/s13139-021-00699-2

Subject(s) - medicine , thyroglobulin , thyroid carcinoma , endocrinology , thyroid , gastroenterology

We investigated whether response classification after total thyroidectomy and radioactive iodine (RAI) therapy could be affected by serum levels of recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin (Tg) measured at different time points in a follow-up of patients with papillary thyroid carcinoma (PTC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research